Constructing a machine learning model for predicting early postoperative recurrence of pancreatic head cancer based on a novel inflammatory factor composite index
Year: 2025
Type: article
Language: en
Topic: Pancreatic and Hepatic Oncology Research
Authors and affiliations:
raw_author_name: Chengkai Yang
raw_affiliation_strings: Department of Hepatopancreatobiliary Oncologic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuma Road 420, Fuzhou, 350000, China
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China
Pancreatic Cancer Institute, Fudan University, Shanghai, 200032, China
Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Shanghai, 200032, China
Shanghai Pancreatic Cancer Institute, Shanghai, 200032, China
raw_author_name: Miaoyan Wei
raw_affiliation_strings: Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China
Pancreatic Cancer Institute, Fudan University, Shanghai, 200032, China
Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Shanghai, 200032, China
Shanghai Pancreatic Cancer Institute, Shanghai, 200032, China
raw_author_name: Qingcai Meng
raw_affiliation_strings: Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China
Pancreatic Cancer Institute, Fudan University, Shanghai, 200032, China
Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Shanghai, 200032, China
Shanghai Pancreatic Cancer Institute, Shanghai, 200032, China
raw_author_name: Jie Hua
raw_affiliation_strings: Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China
Pancreatic Cancer Institute, Fudan University, Shanghai, 200032, China
Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Shanghai, 200032, China
Shanghai Pancreatic Cancer Institute, Shanghai, 200032, China
raw_author_name: Hang Xu
raw_affiliation_strings: Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China
Pancreatic Cancer Institute, Fudan University, Shanghai, 200032, China
Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Shanghai, 200032, China
Shanghai Pancreatic Cancer Institute, Shanghai, 200032, China
raw_author_name: Wei Wang
raw_affiliation_strings: Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China
Pancreatic Cancer Institute, Fudan University, Shanghai, 200032, China
Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Shanghai, 200032, China
Shanghai Pancreatic Cancer Institute, Shanghai, 200032, China
raw_author_name: Xianjun Yu
raw_affiliation_strings: Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China
Pancreatic Cancer Institute, Fudan University, Shanghai, 200032, China
Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Shanghai, 200032, China
Shanghai Pancreatic Cancer Institute, Shanghai, 200032, China
raw_author_name: Hui Zhang
raw_affiliation_strings: Department of Hepatopancreatobiliary Oncologic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuma Road 420, Fuzhou, 350000, China
raw_author_name: Jin Xu
raw_affiliation_strings: Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. xujin@fudanpci.org
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. xujin@fudanpci.org
Pancreatic Cancer Institute, Fudan University, Shanghai, 200032, China. xujin@fudanpci.org
Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Shanghai, 200032, China. xujin@fudanpci.org
Shanghai Pancreatic Cancer Institute, Shanghai, 200032, China. xujin@fudanpci.org